Guest Article by Aoibhinn Collery, Research and Communications Officer, European Institute of Women’s Health It has been over 60 years since the Treaty of Rome, where gender equality was enshrined into EU law, yet no country has succeeded in fully reaching gender...
Guest article by Corinne Hinlopen, Global Health Advocate, WEMOS Foundation Many of us working in public health and aiming to reduce health inequalities know how complex our challenges can be. In the AHEAD project (Action for Health and Equity Addressing medical...
Previous to the publication of the EC proposal to review the EU pharmaceutical legislation, EPHA had called for more transparency of the research and development (R&D) costs for pharmaceutical products. Without clear knowledge of pharmaceutical R&D costs, it...
By Charlotte Roffiaen, France Assos Santé With the COVID-19 pandemic and the multiplication of antibiotic supply disruptions, the fight against medicine shortages has become one of the first priorities of the EU and its Member States. This is perfectly reflected in...
By Dr Ward Rommel, Chair, Access to Medicines Task Force of Association of European Cancer Leagues (ECL) – @CancerLeagues & @WardRommel | #LetsTalkAccess In Europe, around 2.7 million people are diagnosed with cancer every year – and this number is set to...
Guest article by Feras Kasabji [1] and János Sándor [1,2] [1] Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen [2] ELKH-DE Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine,...